Full Text View
Tabular View
Study Results
Related Studies
ESPRIT Study in Hypogonadal Men
This study has been completed.
Study NCT01143818   Information provided by Abbott

First Received on June 9, 2010.   Last Updated on October 12, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypogonadism
More general conditions related to this trial
Endocrine System Diseases
Gonadal Disorders
Interventions listed in this trial
AndroGel (testosterone gel) 1%
Additional drug interventions recognized in this trial
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Abbott
Fovea


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services